Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Esther Sathya Bama Benjamin
Observed name:
Esther Benjamin
Institutions:
Christian Medical College, Vellore,
Sree Chitra Thirunal Institute for Medical Sciences and Technology
Observed institutions:
Christian Medical College, Vellore,
Sree Chitra Thirunal Institute for Medical Sciences and Technology,
Christian Medical College,
International Centre for Genetic Engineering and Biotechnology
ORCID:
0000-0003-4491-7374
Observed ORCID:
0000-0003-4491-7374
OpenAlex ID:
A5043260750
Plasma imatinib levels and ABCB1 polymorphism influences early molecular response and failure-free survival in newly diagnosed chronic phase CML patients
2020
·
Bharathi M. Rajamani
, Esther Sathya Bama Benjamin
, et al.
·
Scientific Reports
·
14
PDF
Efficient deletion of microRNAs using CRISPR/Cas9 with dual guide RNAs
2024
·
Smitha Ijee
, Karthik Chambayil
, et al.
·
Frontiers in Molecular Biosciences
·
10
NUDT15 c.415C>T Polymorphism Predicts 6-MP Induced Early Myelotoxicity in Patients with Acute Lymphoblastic Leukemia Undergoing Maintenance Therapy
2021
·
Aswin Anand Pai
, Ajith Mohan
, et al.
·
Pharmacogenomics and Personalized Medicine
·
9
PDF
Modulating retinoid-X-receptor alpha (RXRA) expression sensitizes chronic myeloid leukemia cells to imatinib in vitro and reduces disease burden in vivo
2023
·
Bharathi M. Rajamani
, Raveen Stephen Stallon Illangeswaran
, et al.
·
Frontiers in Pharmacology
·
5
BCR-ABL1 kinase domain mutation analysis by next generation sequencing detected additional mutations in chronic myeloid leukemia patients with suboptimal response to imatinib
2021
·
Esther Sathya Bama Benjamin
, Niveditha Ravindra
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
4
Immortalised chronic myeloid leukemia (CML) derived mesenchymal stromal cells (MSCs) line retains the immunomodulatory and chemoprotective properties of CML patient-derived MSCs
2024
·
Esther Sathya Bama Benjamin
, Elizabeth Vinod
, et al.
·
Cellular Signalling
·
2
Correction: Modulating retinoid-X-receptor alpha (RXRA) expression sensitizes chronic myeloid leukemia cells to imatinib in vitro and reduces disease burden in vivo
2026
·
Bharathi M. Rajamani
, Raveen Stephen Stallon Illangeswaran
, et al.
·
Frontiers in Pharmacology
PDF
Targeting Cathepsin-G to Overcome Leukemic Stem Cell Persistence in Chronic Myeloid
2026
·
Esther Sathya Bama Benjamin
, Raveen Stephen Stallon Illangeswaran
, et al.
·
Research Square
PDF
Loss of cell cycle regulators RB1 and CDKN2A/2B induces CLL with distinct disease kinetics in murine models and shows distinct outcomes in CLL patients
2025
·
Ivan Negara
, Nevenka Ridova
, et al.
·
Blood
PDF
PD-1 expression on richter syndrome tumor cells does not provide a growth advantage in murine or patient-derived xenograft models In Vivo
2025
·
Ivan Negara
, Esther Sathya Bama Benjamin
, et al.
·
Blood
PDF
3190 – Rxra Mediated Reversal of Imatinib Resistance in Chronic Myeloid Leukemia – a Transcriptomic Profiling Study
2024
·
RAKHI Vidhyadharan
, Raveen Illangeswaran
, et al.
·
Experimental Hematology
Inhibition of BCR::ABL1 tyrosine kinase activity Aids in the Generation of Stable Chronic Myeloid Leukemia Induced Pluripotent Stem Cells
2023
·
Esther Sathya Bama Benjamin
, Dinesh Babu
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
PDF
Rxra Overexpression Improves the Sensitivity to Imatinib In-Vitro/in-Vivo By Disrupting the Oxidative Capacity of Chronic Myeloid Leukemia Cells
2022
·
Raveen Stephen Stallon Illangeswaran
, Bharathi M Rajamani
, et al.
·
Blood
Efficient Knock-out of Serine Protease Cathepsin G Enhances Chemosensitivity to Cytarabine By Modulating the Cytarabine Metabolic Pathway Genes in Acute Myeloid Leukemia
2022
·
Saswati Das
, Raveen Stephen Stallon Illangeswaran
, et al.
·
Blood
Abstract 3153: Imatinib mesylate treatment improves reprogramming efficiency, and morphology of chronic myeloid leukemia derived induced pluripotent stem cells
2022
·
Esther Benjamin
, Gaurav Joshi
, et al.
·
Cancer Research
Abstract 3739: Nuclear hormone receptors modulate imatinib resistance in chronic myeloid leukemia (CML)
2018
·
Bharathi M. Rajamani
, Sreeja Karathedath
, et al.
·
Cancer Research
Show more works
View as search
Works count:
16
Citation count:
44
H-index:
4
I10-index:
2
Year
Topic
Type